Oliver Wyman provides buy-side due diligence and private equity advisory services across sectors including financial services, transportation, healthcare, energy, industrials, technology, aviation, mobility, consumer markets, and infrastructure-related industries.
Kearney provides private equity and due diligence advisory services across commercial, operational, IT, digital, ESG, vendor, and carve-out diligence workstreams.
EY-Parthenon is a major strategy and transactions advisory platform with strong capabilities in commercial due diligence, growth strategy, corporate strategy, and private equity advisory.
Bain & Company is one of the most influential global strategy consulting firms in private equity due diligence, with a long-standing reputation for supporting sponsors across deal screening, commercial due diligence, investment thesis validation, sector strategy, and post-acquis…
Prophet is a growth strategy and transformation consultancy focused on customer-led growth, brand strategy, innovation, marketing, digital transformation, and business transformation.
PMSI Strategy is a specialist strategy consultancy focused on commercial due diligence, market intelligence, strategy consulting, and performance improvement.
MarketBridge is a B2B growth and go-to-market strategy firm focused on helping companies connect strategy, analytics, marketing, sales activation, and measurement.
GCS Insight is a specialist strategy consulting firm providing commercial due diligence, customer value creation, strategic growth, and M&A strategy support.
Ekimetrics is a data science and AI-powered solutions firm focused on helping organizations use analytics to improve marketing, commercial performance, operations, customer understanding, and sustainability-related decision-making.
DeciBio Consulting is a specialist strategy and market intelligence firm focused on precision medicine, diagnostics, research tools, life sciences, and healthcare technology.
ClearView Healthcare Partners is a strategy consulting firm focused on life sciences and healthcare, with strong relevance in commercial due diligence for pharmaceutical, biotechnology, medical device, diagnostics, healthcare services, and life sciences tools assets.